Skip to content
zameds

Clavulanic acid (Clamentin S, Clamentin Sf, Clamentin, Clamgen Iv)

Clavulanic acid

Viatris South Africa (Pty) Ltd

Registration

Applicant
Viatris South Africa (Pty) Ltd
Registrations
5

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Clamentin s

EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 125,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 31,25 mg

Not listed29054029/20.1.2/0540RegisteredNot determinedNone
Clamentin sf

EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250 mg AMOXYCILLIN POTASSIUM CLAVULANATE EQUIVALENT TO 62,5 mg CLAVULANIC ACID

Not listed29054129/20.1.2/0541RegisteredNot determinedNone
Clamentin 375

EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125 mg

37529054229/20.1.2/0542RegisteredNot determinedNone
Clamgen iv 0,6

EACH VIAL CONTAINS AMOXYCILLIN SODIUM EQUIVALENT TO AMOXYCILLIN 500,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 100,0 mg

0,642021242/20.1.2/0212RegisteredNot determinedNone
Clamgen iv 1,2

EACH VIAL CONTAINS AMOXYCILLIN SODIUM EQUIVALENT TO AMOXYCILLIN 1000,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 200,0 mg

1,242021342/20.1.2/0213RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Amoxicillin

    Consolidated Schedules 06 July 2026, line 5238

  • S4: Clavulanic acid

    Consolidated Schedules 06 July 2026, line 5829

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C8H9NO5199.16 g/mol

(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 5280980.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles